HIGHLIGHTS OF THE FOURTH QUARTER
Confirming the trend observed at the end of September, sales revenue of the fourth quarter of 2018 decreased by 0.7 % (- 0.3 % at constant exchange rates). The decrease of sales in France, in Italy and in Spain is mitigated by a growth in the USA and in most other European countries, as well as in Tunisia and in Asia.
YEAR 2018
Annual sales revenue amounted €604,212 thousand, down 2.2% from 2017 (-0.8 % at constant exchange rates).
Given this evolution and in particular the impact of industrial investments, the operating income of 2018 will be down compared to 2017.
With regard to the litigation opposing our Belgium subsidiary UNDA to its former Italian distributor, the arbitration court rendered its ruling on December 18, 2018. This ruling may be subject to a motion of cancellation. The impact on 2018 result is not significant (-€171 thousand).
Our company carries on the development of homeopathy in the world with the same confidence and the same determination.
Laboratoires BOIRON
0 commentaire
Vous devez être membre pour ajouter un commentaire.
Vous êtes déjà membre ? Connectez-vous
Pas encore membre ? Devenez membre gratuitement
Signaler le commentaire
Fermer